References
1. Korsman SNJ, van Zyl GU, Nutt L, Andersson MI, Preiser W. Hepadnaviruses. In: Korsman SNJ, van Zyl GU, Nutt L, Andersson MI, Preiser W, eds. Virology . Edinburgh: Churchill Livingstone; 2012:70-71.
2. Organization WH. Global Hepatitis Report 2017. Geneva2017.
3. Hamoudi W, Qaseer B, Abdallat M, et al. Jordan viral hepatitis B & C 2016. 2016.
4. Batayneh N, Bdour S. Risk of Perinatal Transmission of Hepatitis B Virus in Jordan. Infectious Diseases in Obstetrics and Gynecology. 2002;10(3).
5. Bank-Jordan NB. National Blood bank data Jordan2015.
6. Al Awaidy S, Abu-Elyazeed R, Al Hosani H, et al. Sero-epidemiology of hepatitis B infection in pregnant women in Oman, Qatar and the United Arab Emirates. J Infect. 2006;52(3):202-206.
7. Statistics. Do. Population of Hashemite Kingdom of Jordan According to the 1952, 1961, 1979 ,1994,2015 and 2018 Censuses. . 2018.
8. Adekanle O, Ndububa DA, Olowookere SA, Ijarotimi O, Ijadunola KT. Knowledge of hepatitis B virus infection, immunization with hepatitis B vaccine, risk perception, and challenges to control hepatitis among hospital workers in a Nigerian tertiary hospital. Hepatitis research and treatment. 2015;2015.
9. Hu Y, Dai X, Zhou Y-H, Yang H. A knowledge survey of obstetrics and gynecology staff on the prevention of mother-to-child transmission of hepatitis B virus. The Journal of Infection in Developing Countries. 2013;7(05):391-397.
10. Niu B, Halegoua-De Marzio D, Fenkel JM, Herrine SK. Obstetricians’ and gynecologists’ knowledge, education, and practices regarding chronic hepatitis B in pregnancy. Annals of gastroenterology.2017;30(6):670.
11. Boynton PM, Greenhalgh T. Selecting, designing, and developing your questionnaire. BMJ. 2004;328(7451):1312-1315.
12. Force UPST. Screening for Hepatitis B Virus Infection in Pregnant Women: US Preventive Services Task Force Reaffirmation Recommendation StatementUSPSTF Recommendation: Screening for Hepatitis B Virus Infection in Pregnant WomenUSPSTF Recommendation: Screening for Hepatitis B Virus Infection in Pregnant Women. JAMA.2019;322(4):349-354.
13. Hassan Z, Wahsheh M, Shishani K, Pryor E. Hepatitis needs assessment among Jordanian healthcare workers. International nursing review.2008;55(2):142-147.
14. Chogle N, Chogle M, Divatia J, Dasgupta D. Awareness of post-exposure prophylaxis guidelines against occupational exposure to HIV in a Mumbai hospital. National Medical Journal of India.2002;15(2):69-71.
15. Spada E, Tosti ME, Zuccaro O, Stroffolini T, Mele A, Group CS. Evaluation of the compliance with the protocol for preventing perinatal hepatitis B infection in Italy. Journal of Infection.2011;62(2):165-171.
16. Singh AE, Plitt SS, Osiowy C, et al. Factors associated with vaccine failure and vertical transmission of hepatitis B among a cohort of Canadian mothers and infants. J Viral Hepat. 2011;18(7):468-473.
17. Wiseman E, Fraser MA, Holden S, et al. Perinatal transmission of hepatitis B virus: an Australian experience. Medical Journal of Australia. 2009;190(9):489.
18. Wen WH, Chang MH, Zhao LL, et al. Mother-to-infant transmission of hepatitis B virus infection: significance of maternal viral load and strategies for intervention. J Hepatol. 2013;59(1):24-30.
19. Zou H, Chen Y, Duan Z, Zhang H, Pan C. Virologic factors associated with failure to passive-active immunoprophylaxis in infants born to HBsAg-positive mothers. J Viral Hepat. 2012;19(2):e18-25.
20. Terrault NA, Lok AS, McMahon BJ, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67(4):1560-1599.
21. Seo KI, Bae SH, Sung PS, et al. Effect of antiviral therapy in reducing perinatal transmission of hepatitis B virus and maternal outcomes after discontinuing them. Clinical and molecular hepatology. 2018;24(4):374.
22. Benaboud S, Pruvost A, Coffie PA, et al. Concentrations of tenofovir and emtricitabine in breast milk of HIV-1-infected women in Abidjan, Cote d’Ivoire, in the ANRS 12109 TEmAA Study, Step 2.Antimicrobial agents and chemotherapy. 2011;55(3):1315-1317.
23. Hill JB, Sheffield JS, Kim MJ, Alexander JM, Sercely B, Wendel Jr GD. Risk of hepatitis B transmission in breast-fed infants of chronic hepatitis B carriers. Obstetrics & Gynecology.2002;99(6):1049-1052.
24. Cheung KW, Seto MTY, So PL, et al. The effect of rupture of membranes and labour on the risk of hepatitis B vertical transmission: Prospective multicentre observational study. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2019;232:97-100.
Figure legends
Figure 1. Practitioners response (n=107 ) to “Third-trimester antiviral therapy is recommended for females with high viral loads (>1 million copies/mL or 200,000 IU/mL)”.
*Pearson’s chi -square test.
Figure 2. Associations between the level of specialty and experience of practitioners (n=100) with the screening rates of pregnant females on Hepatitis B during practice.
*Pearson’s chi -square test.
Figure 3. Proportions of practitioners (n=107) and screening rates of HBV for pregnant females in private and public hospitals.
*Pearson’s chi -square test.
Figure 4. Barriers associated with HBV testing in Jordan based on reported practitioners’ perspectives (n= 107).